Skip to content
Open access

Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection

Oct 2026 · Brain, Behavior, & Immunity - Health · Vol 58, pp. 101396 · 0 citations · 47 references
Medicine

TL;DR

Elevated serum levels of transforming growth factor β receptor 2 (TGFBR2) that were significantly higher in those with moderate as compared with those with mild and those without any PCC symptoms may indicate the involvement of TGFBR2 related pathways in the pathogenesis of PCC, in particular in those with cognitive symptoms.

Abstract

Persistent symptoms following the acute phase of SARS-CoV-2 infection have emerged as an increasing health problem. The pathogenesis for the development of post-COVID Condition (PCC) is still elusive. Herein we included serum samples from non-hospitalized (n = 189) and hospitalized (n = 52) COVID-19 patients, representing approximately 90% of all patients with confirmed SARS-CoV-2 infection in the municipality of Bergen, Norway between 28 February and 4 April 2020. The patients were followed clinically with systematic interviews for up to 18 months. Accompanying serum samples were analyzed by un-targeted proteomics and enzyme immunoassay (EIA). Our major findings were: (i) In a subpopulation of the total cohort (n = 69) proteome analyses identified 28 proteins that were dysregulated in individuals with mild and moderate PCC. Pathway analyses suggested the involvement of cell adhesion, extracellular matrix remodeling and immunity. (ii) The most significant finding were elevated serum levels of transforming growth factor β receptor 2 (TGFBR2) that were significantly higher in those with moderate as compared with those with mild and those without any PCC symptoms. (iii) This finding was conformed in the total cohort as assessed by EIA. (iv) The strongest association for TGFBR2 was found for impaired cognition that was seen at both 6, 12 and 18 months after infection. (v) In contrast to the home-isolated patients, no association of TGFBR2 to PCC symptoms were seen for those that were hospitalized during the acute infection. Our finding may indicate the involvement of TGFBR2 related pathways in the pathogenesis of PCC, in particular in those with cognitive symptoms.

Read PDF

Similar papers

Open access Sep 2026

Integrating Anti-SARS-CoV-2 Spike Protein IgG, IL-6, and NK Cell Percentage with Routine Laboratory Markers for COVID-19 Severity Assessment: Development and Validation of the CORIS Nomogram

The CORIS nomogram integrates predictors spanning four dimensions—demographic susceptibility, tissue injury, systemic inflammation, and immune status—to differentiate non-severe from severe or critical COVID-19, and may provide an objective and practical tool for severity assessment at hospital admission.

Yi-He Zhang, Xuan-Ming Xu, Lian Tang et al. · 0 citations
Oct 2026

Circulating SARS-CoV-2 RNA detection in acute COVID-19 disease and Post-COVID Condition.

OBJECTIVES To determine the clinical significance of circulating plasma SARS-CoV-2 RNA across acute COVID-19 and post-COVID condition (PCC) by investigating prevalence, determinants, and kinetics in a large longitudinal cohort, accounting for hospitalization and vaccination. METHODS We consecutively enrolled individu...

Roberta Rovito, L. Terracciano, Giuseppe De Pinto et al. · 0 citations
Open access Sep 2026

Association between the glucose-to-lymphocyte ratio and prognosis in COVID-19 patients

Background The coronavirus disease 2019 (COVID-19) pandemic has transitioned into an endemic stage and is no longer classified as a public health emergency of international concern. Nevertheless, the persistent emergence of novel variants with enhanced transmissibility and immune evasion potential suggests that the dis...

Cong Shi, Sheng-Ping Gong · 0 citations
Open access Sep 2026

Proteomic Profiling of Post-COVID -19 Sequelae.

The emergence of Post-COVID sequelae (PCS) represents a global challenge. However, understanding of biological mechanisms and the definition of quantifiable risk factors remains limited. This study employed machine learning-based classification to explore the potential of proteomics in identifying associations with ind...

Sepehr Golriz Khatami, Rieke Baumkötter, T. Köck et al. · 0 citations
Open access Oct 2026

Blood biomarkers of long COVID: A cross-sectional evaluation of key cytokines and the coordination of inflammation

Introduction Long COVID is a complex pathophysiological condition linked to a heterogenous symptom profile. Dysregulation of 1) immunological and inflammatory responses, 2) endothelial/vascular function, and 3) metabolic and clotting processes have been identified; however, there remains a lack of clinically validated...

Callum Thomas, R. Ashton, E. Pretorius et al. · 0 citations
Open access Nov 2026

Timing dependent associations of acute phase laboratory and antibody parameters with post-acute sequelae of SARS-CoV-2 infection in unvaccinated individuals

Post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) affects a substantial minority of individuals after acute COVID-19, and immune dysregulation is widely implicated in its pathogenesis. Reported associations between SARS-CoV-2-specific antibody responses and PASC ha...

Shinya Yamamoto, T. Ohtsuka, Y. Kishi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.